PharmaMar and Eczasibasi sign a licensing agreement for AplidinĀ® in Turkey
(Pharmamar) PharmaMar (MSE:PHM) has announced today a licensing agreement with Eczasibasi Group to commercialize the marine-derived anticancer drug AplidinĀ® (plitidepsin) ...










